Gupta Ankur, Taqueti Viviany R, van de Hoef Tim P, Bajaj Navkaranbir S, Bravo Paco E, Murthy Venkatesh L, Osborne Michael T, Seidelmann Sara B, Vita Tomas, Bibbo Courtney F, Harrington Meagan, Hainer Jon, Rimoldi Ornella, Dorbala Sharmila, Bhatt Deepak L, Blankstein Ron, Camici Paolo G, Di Carli Marcelo F
Division of Cardiovascular Medicine, Department of Medicine, Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (A.G., V.R.T., N.S.B., P.E.B., S.B.S., T.V., C.F.B., M.H., J.H., S.D., R.B., M.F.D.C.).
AMC Heart Center, Academic Medical Center, University of Amsterdam, The Netherlands (T.P.v.d.H.).
Circulation. 2017 Dec 12;136(24):2325-2336. doi: 10.1161/CIRCULATIONAHA.117.029992. Epub 2017 Sep 1.
It is suggested that the integration of maximal myocardial blood flow (MBF) and coronary flow reserve (CFR), termed coronary flow capacity, allows for comprehensive evaluation of patients with known or suspected stable coronary artery disease. Because management decisions are predicated on clinical risk, we sought to determine the independent and integrated value of maximal MBF and CFR for predicting cardiovascular death.
MBF and CFR were quantified in 4029 consecutive patients (median age 66 years, 50.5% women) referred for rest/stress myocardial perfusion positron emission tomography scans from January 2006 to December 2013. The primary outcome was cardiovascular mortality. Maximal MBF <1.8 mL·g·min and CFR<2 were considered impaired. Four patient groups were identified based on the concordant or discordant impairment of maximal MBF or CFR. Association of maximal MBF and CFR with cardiovascular death was assessed using Cox and Poisson regression analyses.
A total of 392 (9.7%) cardiovascular deaths occurred over a median follow-up of 5.6 years. CFR was a stronger predictor of cardiovascular mortality than maximal MBF beyond traditional cardiovascular risk factors, left ventricular ejection fraction, myocardial scar and ischemia, rate-pressure product, type of radiotracer or stress agent used, and revascularization after scan (adjusted hazard ratio, 1.79; 95% confidence interval [CI], 1.38-2.31; <0.001 per unit decrease in CFR after adjustment for maximal MBF and clinical covariates; and adjusted hazard ratio, 1.03; 95% CI, 0.84-1.27; =0.8 per unit decrease in maximal MBF after adjustment for CFR and clinical covariates). In univariable analyses, patients with concordant impairment of CFR and maximal MBF had high cardiovascular mortality of 3.3% (95% CI, 2.9-3.7) per year. Patients with impaired CFR but preserved maximal MBF had an intermediate cardiovascular mortality of 1.7% (95% CI, 1.3-2.1) per year. These patients were predominantly women (70%). Patients with preserved CFR but impaired maximal MBF had low cardiovascular mortality of 0.9% (95% CI, 0.6-1.6) per year. Patients with concordantly preserved CFR and maximal MBF had the lowest cardiovascular mortality of 0.4% (95 CI, 0.3-0.6) per year. In multivariable analysis, the cardiovascular mortality risk gradient across the 4 concordant or discordant categories was independently driven by impaired CFR irrespective of impairment in maximal MBF.
CFR is a stronger predictor of cardiovascular mortality than maximal MBF. Concordant and discordant categories based on integrating CFR and maximal MBF identify unique prognostic phenotypes of patients with known or suspected coronary artery disease.
有人提出,将最大心肌血流量(MBF)和冠状动脉血流储备(CFR)相结合,即冠状动脉血流容量,可对已知或疑似稳定型冠状动脉疾病患者进行全面评估。由于管理决策基于临床风险,我们试图确定最大MBF和CFR对预测心血管死亡的独立和综合价值。
对2006年1月至2013年12月因静息/负荷心肌灌注正电子发射断层扫描而转诊的4029例连续患者(中位年龄66岁,50.5%为女性)进行MBF和CFR定量分析。主要结局是心血管死亡率。最大MBF<1.8 mL·g·min且CFR<2被视为受损。根据最大MBF或CFR的一致或不一致受损情况确定了四组患者。使用Cox和泊松回归分析评估最大MBF和CFR与心血管死亡的关联。
在中位随访5.6年期间,共发生392例(9.7%)心血管死亡。除传统心血管危险因素、左心室射血分数、心肌瘢痕和缺血、心率血压乘积、所用放射性示踪剂或负荷剂类型以及扫描后血运重建外,CFR比最大MBF更能预测心血管死亡率(调整后的风险比,1.79;95%置信区间[CI],1.38 - 2.31;调整最大MBF和临床协变量后,CFR每降低一个单位,P<0.001;调整CFR和临床协变量后,最大MBF每降低一个单位,调整后的风险比,1.03;95%CI,0.84 - 1.27;P = 0.8)。在单变量分析中,CFR和最大MBF均受损的患者心血管死亡率较高,每年为3.3%(95%CI,2.9 - 3.7)。CFR受损但最大MBF保留的患者心血管死亡率中等,每年为1.7%(95%CI,1.3 - 2.1)。这些患者主要为女性(70%)。CFR保留但最大MBF受损的患者心血管死亡率较低,每年为0.9%(95%CI,0.6 - 1.6)。CFR和最大MBF均保留的患者心血管死亡率最低,每年为0.4%(95%CI,0.3 - 0.6)。在多变量分析中,无论最大MBF是否受损,4个一致或不一致类别中的心血管死亡风险梯度均由CFR受损独立驱动。
CFR比最大MBF更能预测心血管死亡率。基于整合CFR和最大MBF的一致和不一致类别可识别已知或疑似冠状动脉疾病患者独特的预后表型。